| Bioactivity | Amyloid β-Protein (3-42) TFA is a precursor of Pyr peptide. Pyroglutamic acid-modified Aβ (pEAβ) (3-42) is the core of the amyloid plaque in Alzheimer's disease. pEAβ (3-42) accelerates the aggregation of Aβ(1-42), while Aβ(1-42) significantly slows down the primary and secondary nucleation of pEAβ(3-42). | ||||||
| Sequence | Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | ||||||
| Shortening | EFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA | ||||||
| Formula | C196H301N53O56S.xC2HF3O2 | ||||||
| Molar Mass | 4327.87 (free base) | ||||||
| Appearance | 固体 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Amyloid β-Protein (3-42) TFA
CAS: F: C196H301N53O56S.xC2HF3O2 W: 4327.87 (free base)
Amyloid β-Protein (3-42) TFA is a precursor of Pyr peptide. Pyroglutamic acid-modified Aβ (pEAβ) (3-42) is the core o
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.